Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AMERICAN EXPRESS COAXP · Entity 2839 | Director | May 05, 2026 | May 07, 2026 |
| HP INCHPQ · Entity 642 | Chief Financial Officer | August 05, 2026 | August 07, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AMERICAN EXPRESS CO
Report date May 05, 2026 · Filed May 07, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Share Equivalent UnitsSEC Table II · derivative / convertible security | Direct | 9,256.498 |
Reported balance
After 2026-05-05 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-05-05 · Grant · Acquired 742.115 · Balance 9,256.498 F1: Each Share Equivalent Unit reflects the value of one common share. F2: The reported Share Equivalent Units were acquired pursuant to the Directors' Deferred Compensation Plan and will be settled in cash following termination of service as a Director. F3: The Share Equivalent Units are convertible immediately upon termination of service as a Director and have no expiration date. F4: Includes Share Equivalent Units acquired pursuant to a dividend reinvestment feature of the Directors' Deferred Compensation Plan and/or the 2003 Share Equivalent Unit Plan for Directors. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Share Equivalent Unit reflects the value of one common share.
F2: The reported Share Equivalent Units were acquired pursuant to the Directors' Deferred Compensation Plan and will be settled in cash following termination of service as a Director.
F3: The Share Equivalent Units are convertible immediately upon termination of service as a Director and have no expiration date.
F4: Includes Share Equivalent Units acquired pursuant to a dividend reinvestment feature of the Directors' Deferred Compensation Plan and/or the 2003 Share Equivalent Unit Plan for Directors.
HP INC
Report date August 05, 2026 · Filed August 07, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 199,707 |
Ending reported balance
After 2026-08-05 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-08-05 · Exercise / conversion · Acquired 166,746 · Balance 268,880 Row 2 · 2026-08-05 · Tax withholding · Disposed 69,173 · Balance 199,707 F1: Shares withheld by HP to satisfy tax withholding upon vesting of Restricted Stock Units ("RSUs"). |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 152,672 |
Reported balance
After 2026-08-05 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-08-05 · Exercise / conversion · Disposed 166,746 · Balance 152,672 F2: Each RSU represents a contingent right to receive one share of HP common stock. F3: On 8/5/2024, the reporting person was granted 458,015 RSUs, 1/3 of which vest annually over 3 years on 8/5/2025, 8/5/2026 and 8/5/2027, respectively. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 14,074 dividend equivalent units. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares withheld by HP to satisfy tax withholding upon vesting of Restricted Stock Units ("RSUs").
F2: Each RSU represents a contingent right to receive one share of HP common stock.
F3: On 8/5/2024, the reporting person was granted 458,015 RSUs, 1/3 of which vest annually over 3 years on 8/5/2025, 8/5/2026 and 8/5/2027, respectively. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 14,074 dividend equivalent units.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Medtronic plc
Report date August 02, 2024 · Filed August 06, 2024
Section 16 reporting ended · disclosed 2024-08-06. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 46,730 |
Ending reported balance
After 2024-08-02 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2024-08-02 · Exercise / conversion · Acquired 7,132 · Balance 53,459 F1: Represents shares issued upon the settlement of performance-vesting restricted stock units granted on August 2, 2021 and earned dividend equivalents. Row 2 · 2024-08-02 · Tax withholding · Disposed 3,148 · Balance 50,311 F2: Represents shares withheld for taxes upon the settlement of performance-vesting restricted stock units that vested on August 2, 2024. Row 3 · 2024-08-02 · Tax withholding · Disposed 3,581 · Balance 46,730 F3: Represents shares withheld for taxes upon the vesting of restricted stock units previously reported on Table I. |
| Performance Share UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2024-08-02 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2024-08-02 · Exercise / conversion · Disposed 7,132 · Balance 0 F5: Each performance share unit represents a contingent right to receive one share of Medtronic common stock. F6: The performance share units vested on August 2, 2024. |
| Ordinary SharesSEC Table I · non-derivative | IndirectJeffrey S. Parkhill 2021 Irrevocable Trust | 49,859 |
Reported balance
Holding disclosure · report date 2024-08-02 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 49,859 F4: These shares are held in the Jeffrey S. Parkhill 2021 Irrevocable Trust, of which the insider is the trustee and a beneficiary. |
| Ordinary SharesSEC Table I · non-derivative | IndirectBy Child #1 | 843 |
Reported balance
Holding disclosure · report date 2024-08-02 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 843 |
| Ordinary SharesSEC Table I · non-derivative | IndirectBy Child #2 | 843 |
Reported balance
Holding disclosure · report date 2024-08-02 · row 6
Holding and transaction disclosures are not merged.
1 source rowRow 6 · Balance 843 |
| Ordinary SharesSEC Table I · non-derivative | IndirectBy Child #3 | 843 |
Reported balance
Holding disclosure · report date 2024-08-02 · row 7
Holding and transaction disclosures are not merged.
1 source rowRow 7 · Balance 843 |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares issued upon the settlement of performance-vesting restricted stock units granted on August 2, 2021 and earned dividend equivalents.
F2: Represents shares withheld for taxes upon the settlement of performance-vesting restricted stock units that vested on August 2, 2024.
F3: Represents shares withheld for taxes upon the vesting of restricted stock units previously reported on Table I.
F4: These shares are held in the Jeffrey S. Parkhill 2021 Irrevocable Trust, of which the insider is the trustee and a beneficiary.
F5: Each performance share unit represents a contingent right to receive one share of Medtronic common stock.
F6: The performance share units vested on August 2, 2024.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 05, 2026 Filed Aug 7, 2026 20:44 UTC | HP INC HPQ · Entity 642 | Exercise / conversionRestricted Stock Units · Derivative | 166,746 | $0.00 | $0.00 |
DisclosureSEC source: 0001527660-26-000003 · form4-08072026_080848.xml · derivative · entry 3 PARKHILL KAREN L · CIK 0001527660 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 152,672 Underlying: Common Stock · 166,746 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of HP common stock. F3 · price: On 8/5/2024, the reporting person was granted 458,015 RSUs, 1/3 of which vest annually over 3 years on 8/5/2025, 8/5/2026 and 8/5/2027, respectively. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 14,074 dividend equivalent units. F3 · derivative.exercise_date: On 8/5/2024, the reporting person was granted 458,015 RSUs, 1/3 of which vest annually over 3 years on 8/5/2025, 8/5/2026 and 8/5/2027, respectively. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 14,074 dividend equivalent units. F3 · derivative.expiration_date: On 8/5/2024, the reporting person was granted 458,015 RSUs, 1/3 of which vest annually over 3 years on 8/5/2025, 8/5/2026 and 8/5/2027, respectively. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 14,074 dividend equivalent units. Read SEC document |
| August 05, 2026 Filed Aug 7, 2026 20:44 UTC | HP INC HPQ · Entity 642 | Tax withholdingCommon Stock | 69,173 | $28.52 | $1,972,813.96 |
DisclosureSEC source: 0001527660-26-000003 · form4-08072026_080848.xml · nonDerivative · entry 2 PARKHILL KAREN L · CIK 0001527660 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 199,707 F1 · shares: Shares withheld by HP to satisfy tax withholding upon vesting of Restricted Stock Units ("RSUs"). Read SEC document |
| August 05, 2026 Filed Aug 7, 2026 20:44 UTC | HP INC HPQ · Entity 642 | Exercise / conversionCommon Stock | 166,746 | $0.00 | $0.00 |
DisclosureSEC source: 0001527660-26-000003 · form4-08072026_080848.xml · nonDerivative · entry 1 PARKHILL KAREN L · CIK 0001527660 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 268,880 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 05, 2026 Filed May 7, 2026 20:15 UTC | AMERICAN EXPRESS CO AXP · Entity 2839 | GrantShare Equivalent Units · Derivative | 742.115 | $0.00 | $0.00 |
DisclosureSEC source: 0000004962-26-000230 · form4.xml · derivative · entry 1 PARKHILL KAREN L · CIK 0001527660 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,256.498 Underlying: Common Stock · 742.115 shares Expires not disclosed F1 · derivative.exercise_price: Each Share Equivalent Unit reflects the value of one common share. F2 · kind: The reported Share Equivalent Units were acquired pursuant to the Directors' Deferred Compensation Plan and will be settled in cash following termination of service as a Director. F3 · derivative.exercise_date: The Share Equivalent Units are convertible immediately upon termination of service as a Director and have no expiration date. F3 · derivative.expiration_date: The Share Equivalent Units are convertible immediately upon termination of service as a Director and have no expiration date. F4 · balance_after: Includes Share Equivalent Units acquired pursuant to a dividend reinvestment feature of the Directors' Deferred Compensation Plan and/or the 2003 Share Equivalent Unit Plan for Directors. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 21:41 UTC | HP INC HPQ · Entity 642 | GrantRestricted Stock Units · Derivative | 210,305 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001527660-26-000001 · form4-03042026_090306.xml · derivative · entry 1 PARKHILL KAREN L · CIK 0001527660 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 210,305 Underlying: Common Stock · 210,305 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of HP common stock. F2 · shares: On 3/2/2026, the reporting person was granted 210,305 RSUs, 1/2 of which vest 3/2/2027 and 1/2 of which vest 9/2/2027. Dividend equivalent units accrue with respect to these RSUs when and as dividends are paid on HP common stock. F2 · price: On 3/2/2026, the reporting person was granted 210,305 RSUs, 1/2 of which vest 3/2/2027 and 1/2 of which vest 9/2/2027. Dividend equivalent units accrue with respect to these RSUs when and as dividends are paid on HP common stock. F2 · derivative.exercise_date: On 3/2/2026, the reporting person was granted 210,305 RSUs, 1/2 of which vest 3/2/2027 and 1/2 of which vest 9/2/2027. Dividend equivalent units accrue with respect to these RSUs when and as dividends are paid on HP common stock. F2 · derivative.expiration_date: On 3/2/2026, the reporting person was granted 210,305 RSUs, 1/2 of which vest 3/2/2027 and 1/2 of which vest 9/2/2027. Dividend equivalent units accrue with respect to these RSUs when and as dividends are paid on HP common stock. Read SEC document |
| December 08, 2025 Filed Dec 11, 2025 01:48 UTC | HP INC HPQ · Entity 642 | GrantRestricted Stock Units · Derivative | 130,826 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001527660-25-000005 · form4-12112025_011228.xml · derivative · entry 1 PARKHILL KAREN L · CIK 0001527660 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 130,826 Underlying: Common Stock · 130,826 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of HP common stock. F2 · shares: On 12/8/2025, the reporting person was granted 130,826 RSUs, 1/3 of which vest annually over 3 years on the anniversary of 12/7/2025. Dividend equivalent units accrue with respect to these RSUs when and as dividends are paid on HP common stock. F2 · price: On 12/8/2025, the reporting person was granted 130,826 RSUs, 1/3 of which vest annually over 3 years on the anniversary of 12/7/2025. Dividend equivalent units accrue with respect to these RSUs when and as dividends are paid on HP common stock. F2 · derivative.exercise_date: On 12/8/2025, the reporting person was granted 130,826 RSUs, 1/3 of which vest annually over 3 years on the anniversary of 12/7/2025. Dividend equivalent units accrue with respect to these RSUs when and as dividends are paid on HP common stock. F2 · derivative.expiration_date: On 12/8/2025, the reporting person was granted 130,826 RSUs, 1/3 of which vest annually over 3 years on the anniversary of 12/7/2025. Dividend equivalent units accrue with respect to these RSUs when and as dividends are paid on HP common stock. Read SEC document |
| December 07, 2025 Filed Dec 10, 2025 01:09 UTC | HP INC HPQ · Entity 642 | Exercise / conversionRestricted Stock Units · Derivative | 28,570 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001527660-25-000004 · form4-12102025_011211.xml · derivative · entry 3 PARKHILL KAREN L · CIK 0001527660 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,870 Underlying: Common Stock · 28,570 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of HP common stock. F3 · shares: As previously reported, on 12/9/2024, the reporting person was granted 82,305 RSUs, 1/3 of which vest annually over 3 years on the anniversary of 12/7/2024. Dividend equivalent units ("DEUs") accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 1,135 vested DEUs. F3 · price: As previously reported, on 12/9/2024, the reporting person was granted 82,305 RSUs, 1/3 of which vest annually over 3 years on the anniversary of 12/7/2024. Dividend equivalent units ("DEUs") accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 1,135 vested DEUs. F3 · derivative.exercise_date: As previously reported, on 12/9/2024, the reporting person was granted 82,305 RSUs, 1/3 of which vest annually over 3 years on the anniversary of 12/7/2024. Dividend equivalent units ("DEUs") accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 1,135 vested DEUs. F3 · derivative.expiration_date: As previously reported, on 12/9/2024, the reporting person was granted 82,305 RSUs, 1/3 of which vest annually over 3 years on the anniversary of 12/7/2024. Dividend equivalent units ("DEUs") accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 1,135 vested DEUs. Read SEC document |
| December 07, 2025 Filed Dec 10, 2025 01:09 UTC | HP INC HPQ · Entity 642 | Tax withholdingCommon Stock | 12,672 | $25.91 | $328,331.52 |
DisclosureSEC source: 0001527660-25-000004 · form4-12102025_011211.xml · nonDerivative · entry 2 PARKHILL KAREN L · CIK 0001527660 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 102,134 F1 · shares: Shares withheld by HP to satisfy tax withholding upon vesting. Read SEC document |
| December 07, 2025 Filed Dec 10, 2025 01:09 UTC | HP INC HPQ · Entity 642 | Exercise / conversionCommon Stock | 28,570 | $0.00 | $0.00 |
DisclosureSEC source: 0001527660-25-000004 · form4-12102025_011211.xml · nonDerivative · entry 1 PARKHILL KAREN L · CIK 0001527660 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 114,806 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 05, 2025 Filed Aug 7, 2025 20:19 UTC | HP INC HPQ · Entity 642 | Exercise / conversionRestricted Stock Units · Derivative | 158,523 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-021255 · form4-08072025_080820.xml · derivative · entry 3 PARKHILL KAREN L · CIK 0001527660 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 305,344 Underlying: Common Stock · 158,523 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of HP common stock. F3 · price: On 8/5/2024, the reporting person was granted 458,015 RSUs, 1/3 of which vest annually over 3 years on 8/5/2025, 8/5/2026 and 8/5/2027, respectively. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 5,852 dividend equivalent units. F3 · derivative.exercise_date: On 8/5/2024, the reporting person was granted 458,015 RSUs, 1/3 of which vest annually over 3 years on 8/5/2025, 8/5/2026 and 8/5/2027, respectively. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 5,852 dividend equivalent units. F3 · derivative.expiration_date: On 8/5/2024, the reporting person was granted 458,015 RSUs, 1/3 of which vest annually over 3 years on 8/5/2025, 8/5/2026 and 8/5/2027, respectively. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 5,852 dividend equivalent units. Read SEC document |
| August 05, 2025 Filed Aug 7, 2025 20:19 UTC | HP INC HPQ · Entity 642 | Tax withholdingCommon Stock | 72,287 | $25.05 | $1,810,789.35 |
DisclosureSEC source: 0001415889-25-021255 · form4-08072025_080820.xml · nonDerivative · entry 2 PARKHILL KAREN L · CIK 0001527660 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 86,236 F1 · shares: Shares withheld by HP to satisfy tax withholding upon vesting of Restricted Stock Units ("RSUs"). Read SEC document |
| August 05, 2025 Filed Aug 7, 2025 20:19 UTC | HP INC HPQ · Entity 642 | Exercise / conversionCommon Stock | 158,523 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-021255 · form4-08072025_080820.xml · nonDerivative · entry 1 PARKHILL KAREN L · CIK 0001527660 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 158,523 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 29, 2025 Filed May 1, 2025 21:50 UTC | AMERICAN EXPRESS CO AXP · Entity 2839 | GrantShare Equivalent Units · Derivative | 948.467 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-013024 · form4.xml · derivative · entry 1 PARKHILL KAREN L · CIK 0001527660 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,431.438 Underlying: Common Stock · 948.467 shares Expires not disclosed F1 · derivative.exercise_price: Each Share Equivalent Unit reflects the value of one common share. F2 · kind: The reported Share Equivalent Units were awarded pursuant to the Company's 2003 Share Equivalent Unit Plan for Directors and will be settled in cash following termination of service as a Director. F3 · derivative.exercise_date: The Share Equivalent Units are convertible immediately upon termination of service as a Director and have no expiration date. F3 · derivative.expiration_date: The Share Equivalent Units are convertible immediately upon termination of service as a Director and have no expiration date. F4 · balance_after: Includes Share Equivalent Units acquired pursuant to a dividend reinvestment feature of the Directors' Deferred Compensation Plan and/or the 2003 Share Equivalent Unit Plan for Directors. Read SEC document |
| December 09, 2024 Filed Dec 11, 2024 22:03 UTC | HP INC HPQ · Entity 642 | GrantRestricted Stock Units · Derivative | 82,305 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-135436 · ownership.xml · derivative · entry 1 PARKHILL KAREN L · CIK 0001527660 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 82,305 Underlying: Common Stock · 82,305 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of HP common stock. F2 · shares: On 12/9/2024, the reporting person was granted 82,305 RSUs, 1/3 of which vest annually over 3 years on the anniversary of 12/7/2024. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. F2 · price: On 12/9/2024, the reporting person was granted 82,305 RSUs, 1/3 of which vest annually over 3 years on the anniversary of 12/7/2024. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. F2 · derivative.exercise_date: On 12/9/2024, the reporting person was granted 82,305 RSUs, 1/3 of which vest annually over 3 years on the anniversary of 12/7/2024. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. F2 · derivative.expiration_date: On 12/9/2024, the reporting person was granted 82,305 RSUs, 1/3 of which vest annually over 3 years on the anniversary of 12/7/2024. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. Read SEC document |
| August 05, 2024 Filed Aug 6, 2024 21:08 UTC | HP INC HPQ · Entity 642 | GrantRestricted Stock Units · Derivative | 458,015 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-091982 · ownership.xml · derivative · entry 1 PARKHILL KAREN L · CIK 0001527660 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 458,015 Underlying: Common Stock · 458,015 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of HP common stock. F2 · shares: On 8/5/2024, the reporting person was granted 458,015 RSUs, 1/3 of which vest annually over 3 years on the anniversary of 8/5/2024. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. F2 · price: On 8/5/2024, the reporting person was granted 458,015 RSUs, 1/3 of which vest annually over 3 years on the anniversary of 8/5/2024. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. F2 · derivative.exercise_date: On 8/5/2024, the reporting person was granted 458,015 RSUs, 1/3 of which vest annually over 3 years on the anniversary of 8/5/2024. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. F2 · derivative.expiration_date: On 8/5/2024, the reporting person was granted 458,015 RSUs, 1/3 of which vest annually over 3 years on the anniversary of 8/5/2024. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. Read SEC document |
| August 02, 2024 Filed Aug 6, 2024 22:13 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionPerformance Share Units · Derivative | 7,132 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-24-000115 · wk-form4_1722982417.xml · derivative · entry 8 PARKHILL KAREN L · CIK 0001527660 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Performance Share Units · 7,132 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each performance share unit represents a contingent right to receive one share of Medtronic common stock. F6 · derivative.exercise_date: The performance share units vested on August 2, 2024. F6 · derivative.expiration_date: The performance share units vested on August 2, 2024. Read SEC document |
| August 02, 2024 Filed Aug 6, 2024 22:13 UTC | Medtronic plc MDT · Entity 2888 | Tax withholdingOrdinary Shares | 3,581 | $81.51 | $291,887.31 |
DisclosureSEC source: 0001613103-24-000115 · wk-form4_1722982417.xml · nonDerivative · entry 3 PARKHILL KAREN L · CIK 0001527660 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,730 F3 · shares: Represents shares withheld for taxes upon the vesting of restricted stock units previously reported on Table I. Read SEC document |
| August 02, 2024 Filed Aug 6, 2024 22:13 UTC | Medtronic plc MDT · Entity 2888 | Tax withholdingOrdinary Shares | 3,148 | $81.51 | $256,593.48 |
DisclosureSEC source: 0001613103-24-000115 · wk-form4_1722982417.xml · nonDerivative · entry 2 PARKHILL KAREN L · CIK 0001527660 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,311 F2 · shares: Represents shares withheld for taxes upon the settlement of performance-vesting restricted stock units that vested on August 2, 2024. Read SEC document |
| August 02, 2024 Filed Aug 6, 2024 22:13 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionOrdinary Shares | 7,132 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-24-000115 · wk-form4_1722982417.xml · nonDerivative · entry 1 PARKHILL KAREN L · CIK 0001527660 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,459 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares issued upon the settlement of performance-vesting restricted stock units granted on August 2, 2021 and earned dividend equivalents. Read SEC document |
| May 06, 2024 Filed May 8, 2024 19:44 UTC | AMERICAN EXPRESS CO AXP · Entity 2839 | GrantShare Equivalent Units · Derivative | 955.276 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-014562 · form4.xml · derivative · entry 1 PARKHILL KAREN L · CIK 0001527660 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,306.351 Underlying: Common Stock · 955.276 shares Expires not disclosed F1 · derivative.exercise_price: Each Share Equivalent Unit reflects the value of one common share. F2 · kind: The reported Share Equivalent Units were awarded pursuant to the Company's 2003 Share Equivalent Unit Plan for Directors and will be settled in cash following termination of service as a Director. F3 · derivative.exercise_date: The Share Equivalent Units are convertible immediately upon termination of service as a Director and have no expiration date. F3 · derivative.expiration_date: The Share Equivalent Units are convertible immediately upon termination of service as a Director and have no expiration date. F4 · balance_after: Includes Share Equivalent Units acquired pursuant to a dividend reinvestment feature of the Directors' Deferred Compensation Plan and/or the 2003 Share Equivalent Unit Plan for Directors. Read SEC document |
| August 03, 2023 Filed Aug 8, 2023 00:19 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionPerformance Share Units · Derivative | 7,105 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001613103-23-000096 · wk-form4_1691453938.xml · derivative · entry 7 PARKHILL KAREN L · CIK 0001527660 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Performance Share Units · 7,105 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each performance share unit represented a contingent right to receive one share of Medtronic common stock. F5 · price: Each performance share unit represented a contingent right to receive one share of Medtronic common stock. F6 · derivative.exercise_date: The performance share units vested on August 3, 2023. F6 · derivative.expiration_date: The performance share units vested on August 3, 2023. Read SEC document |
| August 03, 2023 Filed Aug 8, 2023 00:19 UTC | Medtronic plc MDT · Entity 2888 | Tax withholdingOrdinary Shares | 5,919 | $84.49 | $500,096.31 |
DisclosureSEC source: 0001613103-23-000096 · wk-form4_1691453938.xml · nonDerivative · entry 2 PARKHILL KAREN L · CIK 0001527660 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,327 F3 · shares: Represents shares withheld for taxes upon the settlement of performance-vesting restricted stock units and restricted stock units that vested on August 3, 2023. Read SEC document |
| August 03, 2023 Filed Aug 8, 2023 00:19 UTC | Medtronic plc MDT · Entity 2888 | GrantOrdinary Shares | 7,105 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-23-000096 · wk-form4_1691453938.xml · nonDerivative · entry 1 PARKHILL KAREN L · CIK 0001527660 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,246 F1 · shares: Represents shares issued upon the settlement of performance-vesting restricted stock units granted on October 9, 2020 and earned dividend equivalents. F2 · balance_after: Includes 723 shares representing earned dividend equivalents upon the settlement of restricted stock units that vested on August 3, 2023 and were previously reported on Table 1. Read SEC document |
| July 31, 2023 Filed Aug 2, 2023 23:43 UTC | Medtronic plc MDT · Entity 2888 | GrantStock Option (Right to Buy) · Derivative | 88,254 | $0.00 Strike: $87.76 | $0.00 |
DisclosureSEC source: 0001613103-23-000070 · wk-form4_1691019823.xml · derivative · entry 7 PARKHILL KAREN L · CIK 0001527660 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 88,254 Underlying: Ordinary Shares · 88,254 shares Expires 2033-07-31 F7 · derivative.exercise_date: These options become exercisable at the rate of 25% of the shares granted beginning on the first anniversary of the grant. Read SEC document |
| July 31, 2023 Filed Aug 2, 2023 23:43 UTC | Medtronic plc MDT · Entity 2888 | GrantPerformance Share Units · Derivative | 31,336 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-23-000070 · wk-form4_1691019823.xml · derivative · entry 6 PARKHILL KAREN L · CIK 0001527660 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,336 Underlying: Performance Share Unit · 31,336 shares Expires not disclosed F4 · derivative.exercise_price: Each performance share unit represents a contingent right to receive one share of Medtronic common stock. F5 · shares: The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 31,336 shares will be issued. If maximum performance metrics are achieved, 62,672 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares. F6 · derivative.exercise_date: Vests on July 31, 2026. F6 · derivative.expiration_date: Vests on July 31, 2026. Read SEC document |
| July 31, 2023 Filed Aug 2, 2023 23:43 UTC | Medtronic plc MDT · Entity 2888 | GrantOrdinary Shares | 12,535 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-23-000070 · wk-form4_1691019823.xml · nonDerivative · entry 1 PARKHILL KAREN L · CIK 0001527660 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,418 F1 · shares: Restrictions on the award shall lapse 100% on the third anniversary of the Grant Date. F2 · balance_after: Includes 921 units acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| May 02, 2023 Filed May 4, 2023 20:15 UTC | AMERICAN EXPRESS CO AXP · Entity 2839 | GrantShare Equivalent Units · Derivative | 1,364.595 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-014467 · form4.xml · derivative · entry 1 PARKHILL KAREN L · CIK 0001527660 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,351.075 Underlying: Common Stock · 1,364.595 shares Expires not disclosed F1 · derivative.exercise_price: The reported Share Equivalent Units were awarded pursuant to the Company's 2003 Share Equivalent Unit Plan for Directors and will be settled in cash following termination of service as a Director. F2 · kind: The reported Share Equivalent Units were awarded pursuant to the Company's 2003 Share Equivalent Unit Plan for Directors and will be settled in cash following termination of service as a Director. F3 · derivative.exercise_date: The Share Equivalent Units are convertible immediately upon termination of service as a Director and have no expiration date. F3 · derivative.expiration_date: The Share Equivalent Units are convertible immediately upon termination of service as a Director and have no expiration date. F4 · balance_after: Includes Share Equivalent Units acquired pursuant to a dividend reinvestment feature of the Directors' Deferred Compensation Plan and/or the 2003 Share Equivalent Unit Plan for Directors. Read SEC document |
| August 01, 2022 Filed Aug 3, 2022 21:24 UTC | Medtronic plc MDT · Entity 2888 | GrantStock Option (Right to Buy) · Derivative | 84,905 | $0.00 Strike: $93.08 | $0.00 |
DisclosureSEC source: 0001127602-22-020404 · form4.xml · derivative · entry 7 PARKHILL KAREN L · CIK 0001527660 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,905 Underlying: Ordinary Shares · 84,905 shares Expires 2032-08-01 F6 · derivative.exercise_date: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. Read SEC document |
| August 01, 2022 Filed Aug 3, 2022 21:24 UTC | Medtronic plc MDT · Entity 2888 | GrantPerformance Share Units · Derivative | 26,859 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-020404 · form4.xml · derivative · entry 6 PARKHILL KAREN L · CIK 0001527660 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,859 Underlying: Performance Share Units · 26,859 shares Expires not disclosed F3 · derivative.exercise_price: Each performance share unit represents a contingent right to receive one share of Medtronic common stock. F4 · shares: The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 26,859 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares. F5 · derivative.exercise_date: Vests on August 1, 2025. F5 · derivative.expiration_date: Vests on August 1, 2025. Read SEC document |
| August 01, 2022 Filed Aug 3, 2022 21:24 UTC | Medtronic plc MDT · Entity 2888 | GrantOrdinary Shares | 10,744 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-020404 · form4.xml · nonDerivative · entry 1 PARKHILL KAREN L · CIK 0001527660 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,962 F1 · shares: The restrictions on the award shall lapse 100% on the third anniversary of the Grant Date. Read SEC document |
| July 29, 2022 Filed Aug 2, 2022 21:22 UTC | Medtronic plc MDT · Entity 2888 | Disposition to issuerOrdinary Shares | 15,151 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-020198 · form4.xml · nonDerivative · entry 1 PARKHILL KAREN L · CIK 0001527660 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,218 F1 · shares: Represents shares of performance-vesting restricted stock granted in July 2019 and earned dividend equivalent units that have been forfeited based on the Company's failure to meet the cumulative three year non-GAAP diluted earnings per share ("EPS") growth performance target. F2 · balance_after: This balance increased by 423 shares due to exempt acquisitions through dividend reinvestment. Read SEC document |
| May 03, 2022 Filed May 5, 2022 20:27 UTC | AMERICAN EXPRESS CO AXP · Entity 2839 | GrantShare Equivalent Units · Derivative | 1,218.1617 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-013490 · form4.xml · derivative · entry 1 PARKHILL KAREN L · CIK 0001527660 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,909.2407 Underlying: Common Stock · 1,218.1617 shares Expires not disclosed F1 · derivative.exercise_price: Each Share Equivalent Unit reflects the value of one common share. F2 · kind: The reported Share Equivalent Units were awarded pursuant to the Company's 2003 Share Equivalent Unit Plan for Directors and will be settled in cash following termination of service as a Director. F3 · derivative.exercise_date: The Share Equivalent Units are convertible immediately upon termination of service as a Director and have no expiration date. F3 · derivative.expiration_date: The Share Equivalent Units are convertible immediately upon termination of service as a Director and have no expiration date. F4 · balance_after: Includes Share Equivalent Units acquired pursuant to a dividend reinvestment feature of the Directors' Deferred Compensation Plan and/or the 2003 Share Equivalent Unit Plan for Directors. Read SEC document |
| March 18, 2022 Filed Mar 21, 2022 23:34 UTC | Medtronic plc MDT · Entity 2888 | SaleOrdinary Shares | 682 | $110.00 | $75,020.00 |
DisclosureSEC source: 0001127602-22-010109 · form4.xml · nonDerivative · entry 1 PARKHILL KAREN L · CIK 0001527660 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,946 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · balance_after: This balance increased by 182 shares due to exempt transactions such as dividend reinvestment. Read SEC document |
| December 06, 2021 Filed Dec 7, 2021 23:23 UTC | Medtronic plc MDT · Entity 2888 | SaleOrdinary Shares | 682 | $110.00 | $75,020.00 |
DisclosureSEC source: 0001127602-21-030500 · form4.xml · nonDerivative · entry 3 PARKHILL KAREN L · CIK 0001527660 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,446 F2 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F3 · balance_after: This balance increased by 154 shares due to exempt transactions such as dividend reinvestment. Read SEC document |
| December 06, 2021 Filed Dec 7, 2021 23:23 UTC | Medtronic plc MDT · Entity 2888 | GiftOrdinary Shares | 49,859 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-030500 · form4.xml · nonDerivative · entry 2 PARKHILL KAREN L · CIK 0001527660 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Jeffrey S. Parkhill 2021 Irrevocable Trust Disclosed balance after: 49,859 F1 · ownership.nature: These shares are held in the Jeffrey S. Parkhill 2021 Irrevocable Trust, of which the insider is the trustee and a beneficiary. Read SEC document |
| December 06, 2021 Filed Dec 7, 2021 23:23 UTC | Medtronic plc MDT · Entity 2888 | GiftOrdinary Shares | 49,859 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-030500 · form4.xml · nonDerivative · entry 1 PARKHILL KAREN L · CIK 0001527660 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Parkhill Family Trust Disclosed balance after: 0 Read SEC document |
| October 08, 2021 Filed Oct 14, 2021 21:41 UTC | Medtronic plc MDT · Entity 2888 | GiftOrdinary Shares | 12,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-027091 · form4.xml · nonDerivative · entry 4 PARKHILL KAREN L · CIK 0001527660 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Parkhill Family Trust Disclosed balance after: 49,859 F1 · ownership.nature: These shares are held in the Parkhill Family Trust, of which the insider is a trustee with her spouse and also a beneficiary with her children. Read SEC document |
| October 08, 2021 Filed Oct 14, 2021 21:41 UTC | Medtronic plc MDT · Entity 2888 | GiftOrdinary Shares | 12,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-027091 · form4.xml · nonDerivative · entry 3 PARKHILL KAREN L · CIK 0001527660 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,974 Read SEC document |
| October 06, 2021 Filed Oct 14, 2021 21:41 UTC | Medtronic plc MDT · Entity 2888 | GiftOrdinary Shares | 37,859 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-027091 · form4.xml · nonDerivative · entry 2 PARKHILL KAREN L · CIK 0001527660 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Parkhill Family Trust Disclosed balance after: 37,859 F1 · ownership.nature: These shares are held in the Parkhill Family Trust, of which the insider is a trustee with her spouse and also a beneficiary with her children. Read SEC document |
| October 06, 2021 Filed Oct 14, 2021 21:41 UTC | Medtronic plc MDT · Entity 2888 | GiftOrdinary Shares | 37,859 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-027091 · form4.xml · nonDerivative · entry 1 PARKHILL KAREN L · CIK 0001527660 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,974 Read SEC document |
| August 02, 2021 Filed Aug 4, 2021 22:23 UTC | Medtronic plc MDT · Entity 2888 | GrantPerformance Share Units · Derivative | 17,904 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-023104 · form4.xml · derivative · entry 8 PARKHILL KAREN L · CIK 0001527660 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,904 Underlying: Performance Share Units · 17,904 shares Expires not disclosed F5 · derivative.exercise_price: Each performance share unit represents a contingent right to receive one share of Medtronic common stock. F6 · shares: The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 17,904 shares will be issued. The actual number of shares to be issued could range from a low of 3,581 at minimum performance to a high of 35,808 shares at maximum performance. If minimum performance metrics are not met, such PSUs may vest at 0 shares. F7 · derivative.exercise_date: Vests on August 2, 2024. F7 · derivative.expiration_date: Vests on August 2, 2024. Read SEC document |
| August 02, 2021 Filed Aug 4, 2021 22:23 UTC | Medtronic plc MDT · Entity 2888 | GrantStock Option (Right to Buy) · Derivative | 1,085 | $0.00 Strike: $131.26 | $0.00 |
DisclosureSEC source: 0001127602-21-023104 · form4.xml · derivative · entry 7 PARKHILL KAREN L · CIK 0001527660 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,085 Underlying: Ordinary Shares · 1,085 shares Expires 2031-08-02 F4 · derivative.exercise_date: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. Read SEC document |
| August 02, 2021 Filed Aug 4, 2021 22:23 UTC | Medtronic plc MDT · Entity 2888 | GrantStock Option (Right to Buy) · Derivative | 61,187 | $0.00 Strike: $131.26 | $0.00 |
DisclosureSEC source: 0001127602-21-023104 · form4.xml · derivative · entry 6 PARKHILL KAREN L · CIK 0001527660 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,187 Underlying: Ordinary Shares · 61,187 shares Expires 2031-08-02 F4 · derivative.exercise_date: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. Read SEC document |
| August 02, 2021 Filed Aug 4, 2021 22:23 UTC | Medtronic plc MDT · Entity 2888 | GrantOrdinary Shares | 7,162 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-023104 · form4.xml · nonDerivative · entry 2 PARKHILL KAREN L · CIK 0001527660 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,833 F3 · kind: The restrictions on the award shall lapse 100% on the third anniversary of the Grant Date. Read SEC document |
| August 02, 2021 Filed Aug 4, 2021 22:23 UTC | Medtronic plc MDT · Entity 2888 | Tax withholdingOrdinary Shares | 6,839 | $131.31 | $898,029.09 |
DisclosureSEC source: 0001127602-21-023104 · form4.xml · nonDerivative · entry 1 PARKHILL KAREN L · CIK 0001527660 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,671 F1 · balance_after: This amount has been adjusted to correct a mathematical error in exempt transactions such as dividend reinvestment. F2 · balance_after: This balance increased by 198 shares due to exempt transactions such as dividend reinvestment. Read SEC document |
| June 22, 2021 Filed Jun 28, 2021 21:21 UTC | Medtronic plc MDT · Entity 2888 | GiftOrdinary Shares | 238 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-020754 · form4.xml · nonDerivative · entry 6 PARKHILL KAREN L · CIK 0001527660 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Child #3 Disclosed balance after: 843 Read SEC document |
| June 22, 2021 Filed Jun 28, 2021 21:21 UTC | Medtronic plc MDT · Entity 2888 | GiftOrdinary Shares | 238 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-020754 · form4.xml · nonDerivative · entry 5 PARKHILL KAREN L · CIK 0001527660 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,509 Read SEC document |
| June 22, 2021 Filed Jun 28, 2021 21:21 UTC | Medtronic plc MDT · Entity 2888 | GiftOrdinary Shares | 238 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-020754 · form4.xml · nonDerivative · entry 4 PARKHILL KAREN L · CIK 0001527660 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Child #2 Disclosed balance after: 843 Read SEC document |
| June 22, 2021 Filed Jun 28, 2021 21:21 UTC | Medtronic plc MDT · Entity 2888 | GiftOrdinary Shares | 238 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-020754 · form4.xml · nonDerivative · entry 3 PARKHILL KAREN L · CIK 0001527660 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,747 Read SEC document |
| June 22, 2021 Filed Jun 28, 2021 21:21 UTC | Medtronic plc MDT · Entity 2888 | GiftOrdinary Shares | 238 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-020754 · form4.xml · nonDerivative · entry 2 PARKHILL KAREN L · CIK 0001527660 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Child #1 Disclosed balance after: 843 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.